Ostéoporose : ce qui a changé en 2022 [Osteoporosis: what's new in 2022]
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_3F0AA8732C68
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Ostéoporose : ce qui a changé en 2022 [Osteoporosis: what's new in 2022]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
18/01/2023
Peer-reviewed
Oui
Volume
19
Numéro
809-10
Pages
62-65
Langue
français
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
The year 2022 has seen numerous studies: questioning the usefulness of vitamin D, the effect of osteoporosis treatments on mortality, and the benefit of parathyroidectomy on fractures in primary hyperparathyroidism. The efficacy of romosozumab is diminished by the treatments prescribed before its introduction. Finally, and fortunately, promising new molecules are available in various countries for the treatment of rare bone diseases.
Mots-clé
Humans, Osteoporosis/drug therapy, Osteoporosis/etiology, Vitamin D/therapeutic use, Fractures, Bone, Bone and Bones, Bone Diseases, Bone Density, Bone Density Conservation Agents/therapeutic use
Pubmed
Création de la notice
31/01/2023 17:39
Dernière modification de la notice
21/10/2023 7:12